BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/5/2017 1:55:00 AM | Browse: 1573 | Download: 2901
Publication Name World Journal of Hepatology
Manuscript ID 34826
Country Italy
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
Manuscript Source Unsolicited Manuscript
All Author List Viola Guardigni, Lorenzo Badia, Matteo Conti, Matteo Rinaldi, Rita Mancini, Pierluigi Viale and Gabriella Verucchi
ORCID
Author(s) ORCID Number
Viola Guardigni http://orcid.org/0000-0002-2769-7325
Lorenzo Badia http://orcid.org/0000-0001-5694-1158
Matteo Conti http://orcid.org/0000-0002-1579-9674
Matteo Rinaldi http://orcid.org/0000-0002-3568-5973
Rita Mancini http://orcid.org/0000-0002-5491-2449
Pierluigi Viale http://orcid.org/0000-0003-1264-0008
Gabriella Verucchi http://orcid.org/0000-0001-6546-0495
Funding Agency and Grant Number
Corresponding Author Viola Guardigni, MD, Department of Medical and Surgical Sciences, University of Bologna, S. Orsola-Malpighi Hospital, via G. Massarenti 9, Bologna 40138, Italy. viola.guardigni2@unibo.it
Key Words Hepatitis C; Direct-acting antivirals; Ribavirin; Therapeutic drug monitoring; Decompensated cirrhosis
Core Tip In this study, patients with decompensated cirrhosis displayed higher plasma ribavirin concentrations in comparison to compensated patients, when treated with Interferon-free regimens for hepatitis C. Higher ribavirin levels were found to lead to greater rates of related toxicities and Child-Pugh class resulted independently associated with ribavirin plasma levels, in our population. Our findings suggest that ribavirin concentrations should be strictly monitored in subjects with advanced liver disease, during direct-acting antivirals-treatment. An early dosage adjustment of ribavirin should be performed when high levels of this antiviral are detected in patients’ plasma, in order to avoid toxicities among these frail individuals.
Publish Date 2017-12-05 01:55
Citation Guardigni V, Badia L, Conti M, Rinaldi M, Mancini R, Viale P, Verucchi G. Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals. World J Hepatol 2017; 9(34): 1270-1277
URL http://www.wjgnet.com/1948-5182/full/v9/i34/1270.htm
DOI http://dx.doi.org/10.4254/wjh.v9.i34.1270
Full Article (PDF) WJH-9-1270.pdf
Full Article (Word) WJH-9-1270.doc